Pesquisar
Can Fite Biopharma Ltd
CANFAdicionar à lista de desejos
4.700USD
+1.730+58.25%
Fechamento 07/01, 16:00（ET）Cotações atrasadas em 15 min
9.80MValor de mercado
PerdaP/L TTM
Mais detalhes de Can Fite Biopharma Ltd Empresa
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Informações de Can Fite Biopharma Ltd
Código da empresaCANF
Nome da EmpresaCan Fite Biopharma Ltd
Data de listagemSep 22, 2005
CEOFishman (Pnina)
Número de funcionários5
Tipo de títulosDepository Receipt
Fim do ano fiscalSep 22
Endereço10 Bareket Street, Kiryat Matalon
CidadePETAH TIKVA
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísIsrael
Código postal49170
Telefone97239241114
Sitehttps://www.canfite.com/
Código da empresaCANF
Data de listagemSep 22, 2005
CEOFishman (Pnina)
Executivos da empresa Can Fite Biopharma Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Yoseph Borenstein
Mr. Yoseph Borenstein
Director
Director
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Can Fite Biopharma Ltd?
Os cinco principais acionistas de Can Fite Biopharma Ltd são: Dr. Sari Fishman, Ph.D.
Quantas instituições possuem ações da Can Fite Biopharma Ltd (CANF)?
Em 2026Q1, 28 instituições possuíam ações da Can Fite Biopharma Ltd, com valor de mercado aproximado de 32.13K, representando 1.50% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -81636.00.